Source disclosure: January 16, 2026
J Frontier Co., Ltd. [2934.T]
TOKYO, Jan 16 (Pulse News Wire) – J Frontier CO.,LTD. (2934.T) reported its fiscal 2026 second quarter earnings on January 14, showing sales of ¥106 billion and EBITDA of ¥1 million, falling short of annual targets.
The company attributed the results to increased advertising investments aimed at securing new regular customers for future quarters. In detail, the Medical Care Sales division saw sales of ¥25 billion and EBITDA of ¥1 million, while Health Sales recorded ¥27 million in sales and ¥1 million in EBITDA. Healthcare Marketing achieved ¥53 billion in sales and ¥1 million in EBITDA.
Despite the lower-than-planned performance, management highlighted positive trends in key performance indicators due to strategic marketing efforts. During the earnings call, CEO Nakamura Atsuhisa addressed investor concerns about ongoing losses, emphasizing that the current investment strategy is expected to yield returns in subsequent quarters. He also noted plans to enhance investor relations activities to support stock price recovery.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing